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Summary
Intermolecular RNA-RNA interactions are used by many noncoding RNAs (ncRNAs) to achieve
their diverse functions. To aid in identifying these contacts, we developed a method based on
RNA Antisense Purification to systematically map RNA-RNA interactions (RAP-RNA) and
applied it to investigate two ncRNAs implicated in RNA processing: U1 snRNA, a component of
the spliceosome, and Malat1, a lncRNA that localizes to nuclear speckles. U1 and Malat1 interact
with nascent transcripts through distinct targeting mechanisms. Using differential crosslinking, we
confirmed that U1 directly hybridizes to both 5’ splice sites and 5’-splice-site motifs throughout
introns and found that Malat1 interacts with pre-mRNAs indirectly through protein intermediates.
Interactions with nascent pre-mRNAs cause U1 and Malat1 to localize proximally to chromatin at
active genes, demonstrating that ncRNAs can use RNA-RNA interactions to target specific pre-
mRNAs and genomic sites. RAP-RNA is sensitive to lower abundance RNAs as well, making it
generally applicable for investigating ncRNAs.
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Introduction
Mammalian genomes encode thousands of noncoding RNAs (ncRNAs), many of which are
implicated in diverse biological processes (Cabili et al., 2011; Carninci et al., 2005; Derrien
et al., 2012; Guttman et al., 2009; 2010). While functional studies have begun to elucidate
the cellular or organismal roles of many ncRNAs (Grote et al., 2013; Guttman et al., 2011;
Sauvageau et al., 2013), the molecular mechanisms by which they accomplish these
functions are harder to characterize. One general approach to gain insights into these
mechanisms is to identify the cellular components with which ncRNAs interact, including
proteins, DNA sites, and RNAs. Notably, many classical ncRNAs interact with other RNAs
either directly through base-pairing (e.g., microRNA-mRNA or snRNA-pre-mRNA
hybridization) or indirectly through protein intermediates (e.g., the multiple ncRNA
components of the ribosome) (Figure S1A). In addition to these examples, numerous large
ncRNAs (lncRNAs) associate with proteins that regulate RNA processing (Änkö et al.,
2012; Tollervey et al., 2011; Wang et al., 2010), suggesting that they may target other RNAs
as part of their regulatory function. These observations suggest that RNA-RNA interactions
may represent a general strategy used by many ncRNAs and that comprehensively mapping
these interactions may provide insight into ncRNA function and mechanism.
Recent RNA-centric biochemical purification techniques, such as RNA Antisense
Purification (RAP) (Engreitz et al., 2013), have enabled the comprehensive mapping of
RNA-DNA interactions in vivo (Chu et al., 2011; Engreitz et al., 2013; Simon et al., 2011).
Despite progress in mapping RNA-DNA interactions, mapping RNA-RNA interactions
remains challenging. Classical RNA-RNA interactions, such as U1 snRNA interactions with
pre-mRNAs, were identified through observations of sequence complementarity (Lerner et
al., 1980) followed by targeted genetics and in vitro affinity experiments (Mount et al.,
1983; Zhuang and Weiner, 1986). Recently, computational and experimental methods have
been developed to search more systematically for RNA-RNA interactions (Dieterich and
Stadler, 2013; Helwak et al., 2013; Kretz et al., 2013; Kudla et al., 2011). However, these
methods do not identify or distinguish between direct and indirect RNA-RNA interactions
and have limited resolution for studying a specific RNA.
To address this challenge, we developed a general method based on RAP to identify the
intermolecular RNA-RNA interactions of a target RNA (RAP-RNA). RAP-RNA identifies
endogenous RNA-RNA complexes through in vivo crosslinking, RNA capture with
antisense oligonucleotides, and high-throughput RNA sequencing. This approach provides a
systematic view of other RNAs that interact with an RNA of interest, and furthermore can
distinguish between direct and indirect RNA-RNA interactions through the use of
crosslinking reagents with different specificity for proteins and nucleic acids.
To demonstrate the utility of this approach, we investigate the RNA-RNA and RNA-
chromatin interactions of two ncRNAs implicated in RNA processing: U1 snRNA and
Malat1 lncRNA. U1 is a core component of the spliceosome that makes direct base-pair
contacts with 5’ splice sites (Mount et al., 1983; Zhuang and Weiner, 1986) and has also
recently been reported to prevent premature cleavage and polyadenylation (PCPA) of
nascent transcripts through interactions outside of 5’ splice sites (Kaida et al., 2010). Malat1
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is a highly conserved lncRNA that localizes to nuclear speckles (Hutchinson et al., 2007)
and interacts with multiple serine/arginine (SR) RNA splicing proteins (Änkö et al., 2012;
Miyagawa et al., 2012; Sanford et al., 2009; Tripathi et al., 2010). While these data suggest
that Malat1 may regulate RNA processing, the exact molecular function of Malat1 remains
elusive (Gutschner et al., 2013).
Here, we show that U1 and Malat1 interact with many nascent pre-mRNAs through distinct
mechanisms: U1 directly hybridizes to 5’ splice sites and at similar binding motifs
throughout introns, whereas Malat1 interacts with pre-mRNAs indirectly via protein
intermediates. These RNA-RNA interactions cause U1 and Malat1 to localize to chromatin
at active genes. Both RNAs localize to DNA in a manner dependent on transcription, but U1
also contacts the 5’ end of active genes in the absence of active transcription. Our findings
demonstrate that mapping RNA-RNA interactions provides insight into the regulatory roles
of ncRNAs and reveal a strategy by which lncRNAs can localize to specific genomic sites.
Results
We set out to adapt RAP to identify direct and indirect RNA-RNA interactions. To this end,
we developed three related protocols: RAP-RNA[AMT], RAP-RNA[FA], and RAP-
RNA[FA-DSG] (Figure S1B). In the RAP-RNA[AMT] protocol, we fixed direct RNA-RNA
hybrids in mouse embryonic stem (ES) cells with 4’-aminomethyltrioxalen (AMT), a
psoralen-derivative crosslinker; AMT generates inter-strand crosslinks between uridine
bases in RNA but does not react with proteins (Calvet and Pederson, 1979; Cimino et al.,
1985). In the RAP-RNA[FA] protocol, we used a different crosslinking strategy to capture
both direct and indirect RNA-RNA interactions: we fixed ES cells using formaldehyde (FA),
which crosslinks protein-RNA and protein-protein interactions and thus can capture both
indirect interactions as well as direct interactions that are caged or flanked by proteins. In
the RAP-RNA[FA-DSG] protocol, we fixed with both FA and disuccinimidyl glutarate
(DSG), a strong protein-protein crosslinker, to more efficiently capture RNAs linked
indirectly through multiple protein intermediates (Figure S1B). In each protocol, we purified
target RNAs with biotinylated antisense oligonucleotides and sequenced co-purifying RNAs
(Experimental Procedures, Table S1).
RAP-RNA Captures U1 snRNA in Complex with 5’ Splice Sites
We first developed RAP-RNA[AMT] to identify direct RNA-RNA interactions at high
resolution (Figure S1). To test this approach, we purified U1 snRNA, a core component of
the spliceosome that makes base-pair contacts with pre-mRNAs at 5’ splice sites (Figure
1A). RAP-RNA[AMT] enriched for U1 by a factor of 54 versus input and strongly enriched
for intronic sequences located 8 nucleotides (nt) downstream of 5’ splice sites (Figure 1B),
precisely where an AMT crosslink would be expected to occur in a canonical U1-pre-mRNA
interaction (Figure 1A). This enrichment extended 200 nt into the intron, likely caused by
intramolecular crosslinks in the pre-mRNA that blocked reverse transcription before it
reached the 5’ splice site (5’ss) (Figure 1A). To test whether RAP-RNA[AMT] could
specifically detect these interactions de novo without prior knowledge of 5’ splice sites, we
looked for enriched 8-mers in the pre-mRNA sequence upstream of each sequencing read:
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the most enriched 8-mer exactly matched the consensus 5’ss motif (17-fold enrichment
versus input, Figure 1C). To confirm that RAP-RNA[AMT] did not capture indirect RNA-
RNA interactions, we examined the enrichment of U2 snRNA, which indirectly interacts
with U1 as part of the spliceosome: U2 was not enriched (0.93-fold versus input). Thus,
RAP-RNA[AMT] can accurately and specifically identify RNA-RNA interactions mediated
by direct hybridization.
U1 snRNA Binds Throughout Nascent Transcripts at 5’-Splice-Site Motifs
In addition to its well-characterized role in splicing, U1 has also recently been implicated in
preventing premature cleavage and polyadenylation (PCPA) of nascent transcripts. In
particular, previous studies have reported that 5’ss mutations alter the location of
transcription termination and that loss-of-function of U1 leads to premature termination of
many pre-mRNAs (Kaida et al., 2010). These observations led to the hypothesis that U1
blocks PCPA by binding to pre-mRNAs at many locations in addition to 5’ splice sites.
However, where U1 localizes on transcripts outside of 5’ splice sites and whether the same
binding motif is responsible for this interaction remain unknown.
To address this question, we used RAP-RNA[AMT] to determine whether U1 interacts
throughout nascent transcripts. Indeed, U1 RAP-RNA[AMT] enriched for 5’ss motifs in
introns, with a level of enrichment that correlated with the strength of the motif match
(Figure 1D). When we analyzed all U1 RAP-RNA[AMT] reads mapping within introns, the
most enriched 8-mer near these reads exactly matched the 5’ss motif (14-fold enrichment,
Figure 1E). To confirm that U1 interacts with these motifs independent of splicing, we
examined U1 interactions with the single-exon Malat1 lncRNA, a 7-kilobase (kb) unspliced
transcript that might require multiple exonic U1 interaction sites to block PCPA (Figure 1F–
H, Experimental Procedures). Indeed, U1 RAP-RNA[AMT] enriched for numerous sites on
Malat1, several of which occurred near conserved 5’ss motifs (e.g., Figure 1G). Because U1
co-localizes with Malat1 in nuclear speckles (Spector and Lamond, 2011), we note that these
interactions might occur with both nascent Malat1 transcripts and mature transcripts that
have been released from chromatin. Together, these results indicate that U1 binds directly to
the 5’ss motif at many sites throughout introns and unspliced transcripts.
RAP-RNA Captures Direct and Indirect RNA-RNA Interactions
We next explored whether capturing both direct and indirect RNA-RNA interactions would
yield broader information about RNA-RNA interactions. In particular, we aimed to use
RAP-RNA to study lncRNAs whose molecular mechanisms are unknown and thus may
interact with other RNAs indirectly. Accordingly, we developed RAP-RNA[FA-DSG] based
on our previously published RAP-DNA protocol, using FA and DSG to crosslink molecular
complexes that include both nucleic acids and proteins.
To test RAP-RNA[FA-DSG], we purified U1 complexes from ES cells crosslinked with FA
and DSG. U1 RAP-RNA[FA-DSG] enriched for U2 snRNA (4-fold versus input) and Malat1
(20-fold versus input), but did not enrich for abundant RNAs, such as U3 snoRNA, that
should not interact with U1 (Figure 2A). Consistent with the role of U1 in pre-mRNA
splicing, U1 RAP-RNA[FA-DSG] enriched more strongly for introns than exons across nearly
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all genes in the genome (Figure 2B,C, Table S2). When we examined individual genes, U1
enrichment extended broadly across entire transcripts and showed only weak enrichment at
5’ splice sites (Figure 2D–F), likely because of the strong protein-protein crosslinking and
large RNA fragment sizes (~1000 nt) in RAP-RNA[FA-DSG] (Figure S1B). Despite this,
some of the most strongly enriched introns showed a very high density of U1 motifs (Figure
2D,E). Introns across the genome with the highest density of U1 motifs (95th percentile,
>30.7 motifs per kb) had on average 14% stronger U1 RAP-RNA[FA-DSG] enrichment than
other introns (P < 10−15, Mann-Whitney test). Together, these data show that RAP-
RNA[FA-DSG] accurately identifies transcripts that interact both directly and indirectly with
U1.
To map specific binding sites within interacting transcripts at higher resolution while
capturing both direct and indirect interactions, we employed a third method, RAP-RNA[FA],
which uses FA crosslinking without DSG and stronger RNA fragmentation prior to capture
(~150 nt) (Figure S1B). Applying the RAP-RNA[FA] approach to U1, we observed strong
enrichment at intronic sites immediately adjacent to 5’ splice sites (Figure 2F). In contrast to
the AMT approach, U1 RAP-RNA[FA] also enriched for intronic sites adjacent to 3’ splice
sites, which interact indirectly with U1 upon formation of the spliceosome complex.
Because U1 binds nearly all nascent transcripts, we confirmed the specificity of the RAP-
RNA[FA] approach by purifying U12 snRNA, a component of the minor spliceosome that
processes a more limited class of ~500 introns with alternative splice-site recognition
sequences (“U12 introns”). U12 RAP-RNA[FA] specifically enriched the 5’ and 3’ splice
sites of U12 introns, while U1 RAP-RNA[FA] did not (Figure 2G). Thus RAP-RNA[FA]
incorporates the strengths of both the RAP-RNA[AMT] and RAP-RNA[FA-DSG] methods:
high resolution for interaction sites and the ability to identify both direct and indirect
interactions.
To test the generality of RAP-RNA to study lower-abundance ncRNAs, we purified the
snoRNAs U3 and Snora73a/U17a, which directly hybridize to specific sites on the pre-
ribosomal 45S transcript to guide pre-rRNA processing. U3 and Snora73a are ~5- and 200-
fold less abundant than U1, respectively (Figure S2A). RAP-RNA[FA] and RAP-RNA[AMT]
correctly identified known interactions between these snoRNAs and 45S, including four
sites for U3 and one site for Snora73a (Figure S2B,C). Interestingly, U3 RAP-RNA[FA]
identified additional, previously unknown binding sites on the 45S pre-rRNA (Figure S2B),
suggesting that U3 may form both direct and indirect contacts with specific sites on the
ribosomal RNA precursor.
Together, these results highlight the utility of RAP-RNA for exploring different types of
RNA-RNA interactions, with each of the three RAP-RNA protocols providing distinct but
complementary information (Figure S1B). The AMT protocol provides information about
direct RNA-RNA interactions at high resolution, but does not identify indirect interactions
and is limited to direct interactions that contain nucleotides that can be crosslinked by
psoralens. The FA protocol provides high resolution for both direct and indirect interactions
using a broadly applicable crosslinker, but may not capture indirect interactions involving
multiple protein intermediates. Finally, the FA-DSG protocol does not map binding sites at
high resolution, but provides the best approach for identifying RNA transcripts that interact
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indirectly through multiple protein intermediates. More generally, the RAP-RNA method
can be combined with additional crosslinking reagents or protocols to fix direct or indirect
RNA-RNA interactions.
Malat1 Interacts with Pre-mRNAs Encoding RNA-Binding Proteins
Having developed three general methods for examining RNA-RNA interactions, we next
used them to study Malat1, a highly conserved lncRNA that localizes to nuclear speckles
(Hutchinson et al., 2007), interacts with multiple SR splicing proteins (Änkö et al., 2012;
Miyagawa et al., 2012; Sanford et al., 2009; Tripathi et al., 2010) and can regulate gene
expression and alternative splicing in some contexts (Eißmann et al., 2012; Nakagawa et al.,
2012; Tripathi et al., 2010; 2013; Zhang et al., 2012). Although these data suggest that
Malat1 may regulate RNA processing, it remains unclear whether this occurs indirectly
through global modulation of SR protein activity (Tripathi et al., 2010) or whether Malat1
may itself interact with pre-mRNAs to more directly guide RNA processing. To test this, we
purified Malat1 using RAP-RNA[AMT], RAP-RNA[FA], and RAP-RNA[FA-DSG], and
achieved >1000-fold enrichment for Malat1 compared to input in all experiments (Figure
2A).
We first examined RAP-RNA[AMT] data for evidence of direct Malat1 interactions with
other RNAs. Consistent with our finding that RAP-RNA[AMT] for U1 enriches for Malat1,
RAP-RNA[AMT] for Malat1 significantly enriched for U1 snRNA in crosslinked (7-fold
versus crosslinked input) but not mock-crosslinked RNA (0.06-fold versus mock-
crosslinked input). We were unable to find any other enriched RNAs or sequence motifs
using this method (Figure S3A). This suggests that either Malat1 does not interact directly
with other RNAs (besides U1) through specific RNA elements or that these interactions do
not contain the sequences required for psoralen crosslinking.
Accordingly, we focused on Malat1 interactions identified by the most inclusive protocol,
RAP-RNA[FA-DSG]. Consistent with the localization of Malat1 in nuclear speckles (Spector
and Lamond, 2011), we observed strong enrichments for both snRNAs and mRNAs (>5-
fold), which are also present in nuclear speckles (Figure 2A). In contrast, Malat1 RAP-
RNA[FA-DSG] strongly depleted other abundant RNAs, such as ribosomal RNAs (>4-fold),
that are not localized in nuclear speckles. Because Malat1 associates with SR splicing
proteins, we next asked whether Malat1 interacts with nascent pre-mRNAs. Indeed, introns
showed stronger enrichment than coding exons (average 5.7-fold versus 1.6-fold,
respectively) across the transcriptome (Figure 3A,B). We confirmed that this enrichment for
introns versus exons did not result from differences in GC-content, which might affect
crosslinking efficiency (Figure S3B). Notably, Malat1 RAP-RNA[FA] showed only weak
enrichment for introns and snRNAs compared to Malat1 RAP-RNA[FA-DSG], suggesting that
Malat1 may interact with these RNAs indirectly through multiple protein intermediates that
are more efficiently crosslinked with DSG (Figure S1B).
We next examined genes with the strongest enrichment (>14-fold versus input) in Malat1
RAP-RNA[FA-DSG] (Table S3). This gene set was enriched for transcripts encoding proteins
involved in RNA binding and splicing (FDR < 0.001, Figure 3B, Figure S3C). Amongst
these highly enriched genes, we observed several remarkable examples where the strongest
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enrichment occurred in introns near alternatively spliced exons (e.g., Figure 3C,D). These
highly-enriched introns contained conserved noncoding elements that are known to control
the generation of unproductive splice isoforms (i.e., isoforms containing premature stop
codons that are subject to nonsense-mediated decay), a frequent mode of auto-regulation for
RNA-binding proteins in which the protein regulates the alternative splicing of its own
transcript (Lareau et al., 2007; Ni et al., 2007; Saltzman et al., 2008). Based on these
examples, we explored whether Malat1 more generally enriches for alternatively spliced
transcripts. Indeed, the introns of genes that have alternatively spliced isoforms were
significantly more enriched for Malat1 binding than introns of genes that do not have
alternative isoforms (22% higher enrichment, P < 10−16, Mann-Whitney test).
To determine whether these patterns were unique to Malat1, we directly compared the RNA
interactions of Malat1 and U1. We ranked nascent transcripts based on their enrichment in
Malat1 RAP-RNA[FA-DSG] versus U1 RAP-RNA[FA-DSG] and found that the most enriched
transcripts were similarly enriched for genes encoding RNA-binding proteins (P < 0.001,
Figure S3D,E). To further demonstrate that Malat1 had a unique pattern of RNA-RNA
interactions that did not reflect nonspecific binding to other nuclear transcripts, we purified
Xist, another abundant nuclear lncRNA. While Xist RAP-RNA[FA-DSG] strongly purified
Xist, it did not show significant enrichment for nascent pre-mRNAs (1.03-fold, P = 0.17,
Mann-Whitney test, Figure S3F). Together, these results demonstrate that Malat1
interactions are distinct from those of other nuclear RNAs. Thus, Malat1 specifically
interacts with many pre-mRNAs and most strongly enriches for alternatively spliced
transcripts, including those that encode RNA-binding proteins.
Malat1 Localizes to Chromatin at Active, Spliced Genes
Because U1 and Malat1 both interact with nascent transcripts, we next explored the
relationship between RNA-RNA interactions and RNA localization to chromatin. To map
RNA-DNA interactions, we isolated and sequenced DNA that co-purified with Malat1 in
cells crosslinked with FA and DSG (RAP-DNA). In a sliding window analysis at 10-kb
resolution, Malat1 RAP-DNA significantly enriched for 4,177 sites across the genome
(Figure 4A, Figure S4A). As negative controls, we performed the same analysis for Xist,
which should only localize to the X-chromosome, and Hdac2 mRNA, which as a coding
transcript is unlikely to interact with chromatin outside its own locus on chromosome 10. As
expected, Xist RAP-DNA did not enrich for any regions outside of the X-chromosome and
Hdac2 RAP-DNA did not enrich for any regions outside of the Hdac2 locus (Figure 4A),
demonstrating the specificity of the RAP method and confirming that Malat1 localizes to
thousands of sites across the genome.
Upon examining the patterns of Malat1 localization to chromatin, we discovered a strong
relationship between Malat1 DNA localization and active transcription. Malat1 was focally
enriched over the bodies of genes that are actively transcribed (Figure 4B), and levels of
Malat1 RAP-DNA enrichment correlated with levels of transcription as defined by the
abundance of chromatin-associated RNA in cell fractionation experiments (Figure 4C,
Pearson’s R = 0.63). Malat1 RAP-DNA enrichment similarly correlated with the amount of
intron RNA captured in the Malat1 RAP-RNA[FA-DSG] experiment (Pearson’s R = 0.64). At
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these active genes, Malat1 was not uniformly enriched across gene bodies but rather showed
enrichment that increased toward and peaked ~500 bases downstream of the annotated
polyadenylation signal (PAS) (Figure 4D), similar to patterns seen for RNA polymerase II
occupancy (Rahl et al., 2010).
Because Malat1 RAP-RNA highlighted Malat1 interactions with alternatively spliced
transcripts, we wondered whether Malat1 localization to chromatin might depend not only
on transcription but also on splicing. To study this, we compared Malat1 RAP-DNA
enrichment at single-exon, multi-exon, and alternatively spliced genes. Because
approximately half of the single-exon genes encode histones, which are processed
differently from other RNAs, we considered histone and non-histone single-exon genes
separately. As noted above, multi-exon genes displayed Malat1 RAP-DNA enrichment that
correlated with the expression level of that gene. In contrast, single-exon histone genes were
significantly depleted in Malat1 RAP-DNA compared to other genes, regardless of their
expression level (Figure 4C, Figure S4B). Single-exon non-histone genes were more
enriched than histone genes, but their enrichment levels did not strongly correlate with
expression levels (Figure 4C). Similar to our observations for RAP-RNA[FA-DSG], Malat1
RAP-DNA preferentially enriched for genes annotated as having alternative isoforms (9%
higher enrichment) and genes encoding proteins involved in RNA binding (20% higher
enrichment) (P < 0.001, Mann-Whitney test), even after controlling for expression level (P <
10−5).
Malat1 Interactions with Chromatin Depend on Transcription at Its DNA Targets
We considered two models to explain these patterns of Malat1 RAP-DNA enrichment at
active, spliced genes. First, Malat1 might localize to DNA through recognition of specific
chromatin elements or DNA signals independent of the presence of the nascent transcript. In
this model, the enrichment for nascent RNAs might simply reflect proximity to the DNA
localization sites of Malat1. Alternatively, Malat1 might localize to chromatin as a
secondary effect of interactions with the nascent pre-mRNA and associated RNA-binding
proteins. We reasoned that halting transcription and repeating the RAP-DNA experiment
would directly distinguish between these two possibilities. If the nascent pre-mRNA were a
key intermediate, then Malat1 would lose its contacts with chromatin upon transcriptional
inhibition. Conversely, if Malat1 localized to gene loci independent of the nascent transcript,
then RAP-DNA enrichment at gene loci would be maintained.
To test this, we repeated the Malat1 RAP-DNA experiment after treating ES cells with an
inhibitor of transcription elongation (flavopiridol) or a control (DMSO). After one hour of
treatment, the abundance of introns in input nuclear-enriched RNA was reduced by on
average 40% across all genes and up to 95% for some genes (Figure S4C,D), consistent with
previous reports (Rahl et al., 2010). We note that the abundance of Malat1 itself did not
measurably decrease during this one-hour interval. When we examined Malat1 localization
across the genome, we found that Malat1 RAP-DNA enrichment at formerly active genes
was significantly reduced (Figure 4D, Figure S4E–H). These results indicate that Malat1
localization to chromatin depends on transcription of its DNA targets.
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These results demonstrate a strong relationship between the RNA and DNA interactions of
Malat1 and suggest a model where Malat1 localization to chromatin occurs through
interactions with nascent pre-mRNAs (Figure 5A). Through these interactions, Malat1 is
brought in proximity to chromatin and thus purifies DNA at active gene loci. This model
explains our observation of RAP-DNA enrichment accumulating over active gene loci, as
the amount of Malat1 associated with a position along a gene locus would depend on the
length of the pre-mRNA tethered to that location, which increases from the 5’ end to the 3’
end.
U1 Localizes to Chromatin in Two Distinct Ways
We next explored whether the chromatin localization of U1 also depends on transcription of
its DNA targets. We found that U1 was indeed enriched over the bodies of active genes and
showed a level of enrichment that correlated with the abundance of chromatin-associated
input RNA (Figure 4E, Pearson’s R = 0.70). At higher resolution across active genes,
however, U1 RAP-DNA enrichment showed a striking bimodal pattern: U1 showed elevated
enrichment both at the 5’ and 3’ ends of genes (Figure 4F, Figure S4E–G). Because these
peaks appeared to extend over several kilobases and might be confounded by the inclusion
of shorter genes, we performed the same analysis using only genes that are longer than 20
kb. In these genes, U1 RAP-DNA exhibited a sharp peak at the 5’ end (average of 0.8 kb)
and a broader peak at the 3’ end (average of 4 kb) (Figure S4I).
Based on this bimodal pattern of enrichment, we hypothesized that U1 might interact with
chromatin by two distinct mechanisms: one that would lead to enrichment at the 3’ ends of
genes dependent on interactions with the nascent pre-mRNA, similar to Malat1; and one that
would lead to its localization to DNA at the 5’ ends of genes near the transcription start site
(TSS), possibly independent of interactions with the nascent transcript (Figure 5B). To gain
insight into these mechanisms, we performed U1 RAP-DNA in cells treated with
flavopiridol. Under these conditions, the U1 RAP-DNA peak at the 3’ ends of genes largely
disappeared, similar to our results for Malat1 (Figure 4F, Figure S4E–G). At the 5’ ends of
genes, however, U1 enrichment was maintained even in the absence of transcription
elongation (Figure 4F), suggesting that U1 may interact with these sites through a
mechanism that does not involve interactions with pre-mRNAs. Indeed, we found that U1
localization to the 5’ ends of genes did not depend on the presence of a 5’ss motif in the
short nascent RNA produced by transcription initiation (Figure S4J,K). These results
demonstrate that U1 localizes to chromatin in two ways (Figure 5B). First, U1 binds nascent
RNAs and through these interactions co-purifies active gene loci. Second, U1 binds
chromatin at the 5’ ends of genes through a mechanism that does not depend on transcription
elongation or on 5’ss motifs near the TSS.
Discussion
Here we developed RAP-RNA, a method to comprehensively characterize in vivo RNA-
RNA interactions, and applied it to investigate two ncRNAs implicated in RNA processing:
U1 and Malat1. We show that RAP-RNA can map RNA-RNA interactions at high
resolution and distinguish between hybridization- and protein-mediated binding, providing a
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powerful tool for exploring RNA function across a wide range of applications including
identifying microRNAs that bind a specific mRNA, characterizing transcripts associated
with ribosomes, or illuminating the regulatory functions of the many uncharacterized large
and small ncRNAs implicated in gene regulation and human disease.
Using RAP, we find that U1 and Malat1 interact with many nascent RNAs and chromatin
loci. U1 binding is pervasive throughout the transcriptome including introns and unspliced
genes, and occurs through direct hybridization with the canonical 5’ss motif (Figure 5B).
Together with the recent evidence that U1 acts to prevent PCPA (Kaida et al., 2010), our
results suggest that U1 may play a ubiquitous role in protecting the integrity of the
transcriptome through direct engagement of nascent transcripts. We also found that U1 can
localize to DNA near TSSs independent of its interactions with nascent RNA. Notably,
previous studies have reported that U1 directly binds TFIIH, a general transcription factor,
and that this interaction enhances transcription initiation and reinitiation in reconstituted
transcription assays in vitro (Kwek et al., 2002; O'Gorman et al., 2005). Furthermore,
promoter-proximal 5’ splice sites can enhance transcription in vivo by recruiting basal
transcription factors (Damgaard et al., 2008). In light of these previous observations, our
results suggest that U1 may regulate transcription initiation throughout the genome.
Our data also provide new insight into the molecular function of Malat1. While some
previous studies have shown that Malat1 depletion can affect alternative splicing (Tripathi et
al., 2010) and reduce recruitment of SR proteins to a gene locus (Bernard et al., 2010), the
molecular functions of Malat1 remain unclear (Gutschner et al., 2013). Our data demonstrate
that Malat1 interacts with many nascent pre-mRNAs at active gene loci, raising the
possibility that Malat1 may influence RNA processing through recruitment or modification
of other proteins localized to these sites. Notably, Malat1 interacts indirectly with numerous
alternatively spliced, auto-regulated transcripts encoding RNA-binding proteins, including
some that are thought to physically interact with Malat1 (Änkö et al., 2012; Pandit et al.,
2013). Based on these observations, we propose that Malat1 may interact with pre-mRNAs
through its physical associations with SR splicing proteins (Figure 5A) (Tripathi et al.,
2010). Indeed, previous work has shown that tethering SRSF1 to a transgenic chromatin
locus is sufficient to recruit MALAT1 to that locus (Tripathi et al., 2012). Thus, interactions
with sequence-specific SR splicing proteins may provide a mechanism for Malat1
recruitment to specific alternatively spliced pre-mRNAs and active gene loci on chromatin.
More generally, our observations suggest that nuclear-localized lncRNAs can recognize
nascent pre-mRNAs to guide their regulatory functions. LncRNAs might achieve specificity
for these nascent transcripts through direct hybridization or sequence-specific RNA-binding
proteins, enabling localization to specific pre-mRNAs or chromatin sites. In some cases,
these lncRNAs may directly target nascent RNAs to control RNA processing. In other cases,
this recruitment may enable lncRNA-mediated regulation of chromatin or transcription at
the gene locus. These two possibilities are not mutually exclusive: numerous lncRNAs
interact with chromatin regulatory complexes and RNA processing proteins, suggesting that
these lncRNAs may also associate with specific nascent RNAs to control pre-mRNA
processing and/or regulate chromatin. In contrast to other mechanisms for lncRNA
localization such as interactions with DNA-binding proteins (Soruco et al., 2013) or
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proximity-mediated search (Engreitz et al., 2013), lncRNA targeting through sequence-
specific RNA-RNA interactions might enable integration of co-transcriptional (on-
chromatin) and post-transcriptional (off-chromatin) regulatory signals. Future work will be
required to determine the prevalence and functions of these lncRNA-RNA interactions.
RAP-RNA provides a powerful tool to investigate these possibilities and to further dissect
the relationship between RNA-RNA interactions, RNA localization to chromatin, and
transcriptional regulation.
Experimental Procedures
Detailed RAP protocols are available at the authors’ web site: http://
www.lncrna.caltech.edu/RAP. Sequencing data are available at the NCBI Gene Expression
Omnibus (accession number GSE55914).
Cell Culture
For most experiments, we cultured V6.5 male mouse ES cells in 2i + LIF; for experiments
involving Xist, we used pSM33 male mouse ES cells induced with doxycycline for three
hours to activate Xist expression (Engreitz et al., 2013). For transcription inhibition, we
treated cells with 1 µM flavopiridol or DMSO for one hour.
Probe Design and Generation
We captured target RNAs using pools of ssDNA biotinylated oligos. To generate tiled
probesets to capture long RNAs (>250 nucleotides), we synthesized barcoded pools of
oligos with 120-nt complementarity to the target RNA (Engreitz et al., 2013) (Table S4). We
amplified specific probe subsets (Table S5) and generated ssDNA probes through in vitro
transcription of dsDNA templates followed by reverse transcription with a 5’-biotinylated
ssDNA primer. To capture short RNAs (<250 nucleotides), we designed and directly
purchased three to four 50-nt 5’biotinylated ssDNA oligos (Table S4).
RAP with FA or FA-DSG Crosslinking
For the FA protocol, we crosslinked cells with 2% FA and solubilized chromatin with strong
sonication, yielding RNA fragments of ~150 nt. For the FA-DSG protocol, we crosslinked
cells with 2 mM DSG followed by 3% FA and solubilized chromatin with light sonication
followed by treatment with DNase I to preserve RNA integrity. We performed RAP as
previously described (Engreitz et al., 2013), with modifications (see Extended Experimental
Procedures). We used 5 million cells and 50 pmol ssDNA probe per experiment, incubating
in a highly denaturing buffer at 37 °C for 2 hours. We washed six times at 45 °C, then eluted
the target RNA and co-purified complexes with RNase H. We digested protein with
Proteinase K, isolated nucleic acids, and proceeded to RNA or DNA sequencing.
RAP with AMT Crosslinking
We resuspended cells in 0.5 mg/mL AMT solution (+AMT) or PBS only (−AMT) and
irradiated the cells in a tissue culture dish for 7 minutes with long-wave ultraviolet light. We
performed nuclear enrichment, isolated nucleic acids using TRIzol, fragmented the RNA to
a median size of ~100 nt, and then digested residual DNA. We used 2 µg of the resulting
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purified RNA and 15 pmol ssDNA probe per purification. We used an alternate set of
denaturing buffers for the AMT protocol hybridization and washes (see Extended
Experimental Procedures).
Negative Controls for RAP-RNA
We performed numerous negative controls to eliminate potential sources of technical
artifacts in the RAP-RNA protocols. For RAP-RNA[AMT], these include off-target
hybridization between the probes and other RNAs, and interactions between other RNAs
and the streptavidin beads. To control for these potential issues, we performed the
experiment in parallel with a −AMT control, which was treated identically to the +AMT
sample except that AMT was not added prior to UV irradiation. For RAP-RNA[FA-DSG], the
potential sources of background additionally include off-target hybridization with DNA and
nonspecific interactions between the probes and proteins that are crosslinked to RNA. To
account for these potential issues, we performed two controls. First, we performed RAP-
RNA experiments in non-crosslinked lysate. Second, we purified an mRNA as well as other
abundant nuclear RNAs from crosslinked lysate. We searched for artificial peaks across the
transcriptome in these control experiments and in some cases identified elevated signals at
GC-rich simple or tandem repeats and the surrounding RNA sequences. These signals were
clearly recognizable as probe-RNA hybridization artifacts by their characteristic read
distributions, which result from RNase H cleavage during the elution step. We verified that
these artificial signals did not affect our results and conclusions (see Extended Experimental
Procedures).
Sequencing and Alignment
We sequenced each library to a depth of 10–50 million read-pairs, depending on the
estimated library complexity. To analyze RNA sequencing data, we filtered reads aligning to
highly abundant RNA transcripts, including rRNA, snRNA, and repeat elements defined by
RepeatMasker. We aligned all remaining reads to the mouse transcriptome (RefSeq) and
genome (mm9) using Tophat and discarded reads with MAPQ < 30. To analyze DNA
sequencing data, we aligned reads to the mouse genome (mm9), removed duplicate read-
pairs, and discarded reads with MAPQ < 30.
Enrichment Calculations
To calculate the enrichment for a target RNA, we divided the fraction of reads mapping to
the target RNA in RAP-RNA by the same fraction in input. To calculate the enrichment for
all other non-target RNAs or sets of RNAs, we performed the same calculation, except that
we subtracted the number of reads mapping to the target RNA from the total read counts.
Peak Calling
We called peaks in RAP-RNA data for the AMT, FA, and non-crosslinked experiments
using a sliding-window approach at 10 or 100-nucleotide resolution, comparing the number
of reads in the purification sample with the number of reads in the input or control sample
using a binomial test (see Extended Experimental Procedures). For RAP-RNA[FA-DSG], we
focused on enrichments averaged across entire transcripts (exons or introns) rather than in
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smaller windows due the lower resolution of this approach for specific RNA interaction
sites.
Analysis of 5’ Splice Sites
To relate RAP-RNA[AMT] reads to 5’ splice sites, we calculated the minimum distance from
the 5’ base of the second read in each read-pair to any 5’ splice site (defined by RefSeq). To
identify motifs enriched in RAP-RNA[AMT], we counted 8-mer sequences contained within
30 bases upstream of the second-of-pair read-ends and assessed significance with Fisher’s
exact test (P < 0.001 after Bonferroni correction).
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Highlights
- A general method to identify RNA-RNA interactions for many RNAs (>80
nucleotides)
- Distinguishes direct and indirect RNA-RNA interactions using different
crosslinkers
- U1 snRNA interacts with pre-mRNAs directly while Malat1 lncRNA
interacts indirectly
- RNA-RNA interactions target U1 and Malat1 to chromatin at active gene loci
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Figure 1. U1 Binds Throughout Nascent Transcripts at 5’-Splice-Site Motifs
(A) Schematic diagram of U1 RAP-RNA[AMT]. AMT forms covalent crosslinks (orange)
between opposing uridine bases in the U1 snRNA (red) and target pre-mRNA (gray).
Consensus sequences show canonical base-pairing interaction. To avoid capturing indirectly
associated RNAs, we digested protein and DNA before purifying U1 with biotinylated
antisense probes (blue). To map RNA-RNA interaction sites at high resolution, we
fragmented RNA prior to capture and performed reverse transcription (RT) without reversal
of crosslinks, leading to complementary DNA (cDNA, purple) that terminates at or near the
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site of a crosslink (see also Figure S1). Ligation of a second adapter to the 3’ end of the
cDNA enabled sequencing and mapping the positions of RT termination.
(B) Read counts aggregated over all 5’ splice sites. Each read-pair contributes a count in the
base corresponding to the 5’ end of the original RNA fragment. Cells were crosslinked with
AMT (+AMT, red) or mock-crosslinked with DMSO (−AMT, blue). Crosslinked input RNA
(black) is shown for comparison.
(C) Enrichment for every 8-mer RNA motif close to RAP-RNA sequencing reads. Colored
dots represent 8-mers that are significantly enriched in U1 RAP-RNA versus input (P <
0.001 after Bonferroni correction, enrichment >= 4). Red, orange, and yellow dots
correspond to 8-mers that have a Levenshtein edit distance from the 8-mer consensus motif
of 1, 2, or >2, respectively.
(D) Enrichment for sequencing reads in U1 RAP-RNA[AMT] versus input at 5’ splice sites
and at 5’ss motif matches >200 bases away from exons. Enrichments are normalized to the
enrichment at random intronic sites >200 bases away from exons. 5’ss motif matches were
classified as strong, medium, or weak as previously described (Almada et al., 2013). Strong
AS = strong motifs on the antisense strand, which should not be bound by U1.
(E) Same as (C), but considering only reads that map to introns >200 bases away from
exons.
(F) U1 RAP-RNA[AMT] coverage and enrichment across the Malat1 transcript (10-nt
resolution), representing the ratio of U1 RAP +AMT and the maximum of U1 RAP −AMT
and Input +AMT. Black bars represent significantly enriched windows (P < 0.001 after
Bonferroni correction). Conservation represents the phyloP30wayPlacental track from the
UCSC Genome Browser.
(G) and (H) Zoom-in on two significant U1 binding sites. Scales on y-axes are the same as
in (F).
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Figure 2. RAP-RNA Captures Both Direct and Indirect RNA-RNA Interactions
(A) Enrichment for individual transcripts or classes of RNAs. RAP-RNA[FA-DSG]
experiments include two replicate U1 and Malat1 purifications (rep1 and rep2) and one
Hdac2 purification (negative control).
(B) Each point represents the average U1 RAP-RNA[FA-DSG] enrichment across all introns
(black) or exons (gray) for one gene. The x-axis represents the expression of the mature
transcript (exons) in input nuclear-enriched RNA in reads per kilobase per million (RPKM).
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(C) Comparison of U1 RAP-RNA[FA-DSG] enrichment for the exons (gray) and introns
(black) of all genes.
(D) RAP-RNA[FA-DSG] sequencing reads mapping to Gpi1 and (E) Ptbp3, two of the most
highly enriched transcripts in U1 RAP-RNA[FA-DSG] (>100-fold versus input). Gray
rectangles highlight enriched introns with many U1 motifs (purple).
(F) Enrichment of sequencing reads in RAP-RNA[FA] versus input aggregated across 5’ and
3’ splice sites for all introns (n > 180,000) or (G) U12 introns (n = 588). U1 RAP-RNA[FA]
(red) more strongly enriches splice sites than U1 RAP-RNA[FA-DSG] (gray). Each read-pair
contributes a count at the position corresponding to the 3’ end of the original RNA fragment
for the 5’-splice-site panel and the 5’ end for the 3’-splice-site panel. See also Figure S2.
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Figure 3. Malat1 Interacts Indirectly with Nascent Transcripts Encoding RNA-Binding Proteins
(A) Malat1 RAP-RNA[FA-DSG] enrichment at exons and introns, similar to Figure 2B.
(B) Comparison of Malat1 RAP-RNA[FA-DSG] enrichment for the exons (gray) and introns
(black) of all genes or of significant gene sets. See also Figure S3.
(C) Malat1 RAP-RNA[FA-DSG] sequencing reads mapping to Hnrnpdl and (D) Tial1, two
highly enriched genes encoding RNA-binding proteins. Gray rectangles highlight conserved
introns containing RNA elements that control alternative splicing.
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Figure 4. Chromatin Localization of U1 and Malat1
(A) Significance of enrichment across the genome in 10-kb windows for Malat1, U1, Xist,
and Hdac2 RAP-DNA. Y-axis represents uncorrected binomial P-values, and the red lines
mark the cutoff for genome-wide significance (P < 10−10). Ticks at the bottom denote the
locations of the genes encoding each RNA. U1 is encoded on chromosomes 3, 11, and 12.
(B) RAP-DNA enrichment versus input across a region containing several active genes
(chr18: 34,313,699–35,191,532). RNA sequencing of input total RNA shows relative gene
expression.
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(C) Scatterplot shows Malat1 RAP-DNA enrichment versus levels of chromatin-associated
RNA for single-exon histone genes (purple), single-exon non-histone genes (red), and all
other genes (dark gray). Dashed lines represent linear regressions. R = Pearson’s correlation.
(D) RAP-DNA enrichment averaged over active genes (black), inactive genes (blue), and
active genes in cells treated with flavopiridol (black dashed line). Shaded regions represent
95% confidence intervals for the average enrichment. For Malat1, the averages represent the
5% of active genes with the highest Malat1 enrichment and an equal number of randomly
selected inactive genes.
(E) Same as (C) for U1 RAP-DNA.
(F) Same as (D) for U1 RAP-DNA. For U1, average enrichments include all active and
inactive genes. Notable peaks occur at the transcription start site (TSS) and at the
polyadenylation site (PAS). See also Figure S4.
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Figure 5. Malat1 and U1 Interact with Pre-mRNAs and Chromatin Through Different
Mechanisms
(A) Malat1 interacts indirectly with nascent RNAs at splicing regulatory elements, like the
conserved noncoding elements in Hnrnpdl and Tial1, possibly through its known
interactions with SR splicing proteins (Tripathi et al., 2010). These interactions enable
Malat1 to localize to chromatin at active gene loci. Malat1 RAP may co-purify DNA
through tethering of the nascent transcript to chromatin by RNA polymerase.
(B) U1 interacts with pre-mRNAs through direct hybridization, both at 5’ splice sites and
throughout introns. U1 interacts with chromatin through two different mechanisms: (i) U1
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localizes throughout active gene loci as a secondary result of its direct interactions with the
nascent pre-mRNA, and (ii) U1 localizes at the 5’ ends of genes through a mechanism that
does not depend on transcriptional elongation, perhaps via known interactions with the
cyclin H subunit of TFIIH (Kwek et al., 2002). While these figures depict interactions with
chromatin-associated pre-mRNAs, U1 and Malat1 may also interact with pre-mRNAs after
their release from chromatin. snRNP: small nuclear ribonucleic particle.
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